Formulation insights, R&D matrix updates, and contract manufacturing services from Olympia Biosciences™ — Europe's evidence-based supplement CDMO.https://olympiabiosciences.com/jahttps://olympiabiosciences.com/ja/rd-hub/bbb-permeable-nanomicelles-cognitive-formulation/https://olympiabiosciences.com/ja/rd-hub/bbb-permeable-nanomicelles-cognitive-formulation/Large, highly lipophilic botanical extracts and cognitive enhancers fail to efficiently cross the blood-brain barrier (BBB) via standard oral delivery.https://olympiabiosciences.com/ja/rd-hub/sustained-release-catecholamine-modulators-cdmo/https://olympiabiosciences.com/ja/rd-hub/sustained-release-catecholamine-modulators-cdmo/Standard dopaminergic precursors cause sharp neurochemical spikes followed by severe crashes, disrupting sustained executive function.https://olympiabiosciences.com/ja/rd-hub/endocrine-metabolic-womens-health-formulation/https://olympiabiosciences.com/ja/rd-hub/endocrine-metabolic-womens-health-formulation/Stabilizing highly sensitive isomeric ratios (e.g., 40:1 Myo-inositol to D-chiro-inositol) alongside liposomal antioxidants in a unified, high-payload matrix to reduce pill burden.https://olympiabiosciences.com/ja/rd-hub/glycolysis-restricted-fsmp-contract-manufacturing/https://olympiabiosciences.com/ja/rd-hub/glycolysis-restricted-fsmp-contract-manufacturing/Masking severe dysgeusia while delivering high-density, zero-carbohydrate lipid calories without thermal degradation during clinical pasteurization.https://olympiabiosciences.com/ja/rd-hub/clinical-grade-liposomal-antioxidants-cdmo/https://olympiabiosciences.com/ja/rd-hub/clinical-grade-liposomal-antioxidants-cdmo/Achieving intravenous-comparable plasma concentrations of critical antioxidants (e.g., Glutathione, Vitamin C) via oral administration due to rapid oxidation.https://olympiabiosciences.com/ja/rd-hub/longevity-senolytics-custom-formulation/https://olympiabiosciences.com/ja/rd-hub/longevity-senolytics-custom-formulation/NAD+ precursors and phytosenolytics (e.g., Fisetin, Spermidine) exhibit extremely poor aqueous solubility, rapid gastric degradation, and low intracellular penetrance.https://olympiabiosciences.com/ja/rd-hub/targeted-postbiotics-gut-brain-cdmo/https://olympiabiosciences.com/ja/rd-hub/targeted-postbiotics-gut-brain-cdmo/Potent short-chain fatty acids (SCFAs) like Butyrate possess a highly offensive odor and degrade before reaching the targeted lower gastrointestinal tract.https://olympiabiosciences.com/ja/rd-hub/neuro-metabolic-cognitive-support-cdmo/https://olympiabiosciences.com/ja/rd-hub/neuro-metabolic-cognitive-support-cdmo/Providing alternative cerebral energy substrates (ketone precursors) without causing extreme gastrointestinal distress typical of high-dose medium-chain triglycerides.https://olympiabiosciences.com/ja/rd-hub/nanomicellar-endothelial-support-cdmo/https://olympiabiosciences.com/ja/rd-hub/nanomicellar-endothelial-support-cdmo/Potent venotonic flavonolignans (e.g., Diosmin, Hesperidin) are massive, highly hydrophobic brick-dust molecules with standard oral bioavailability often below 2%, classified as BCS Class IV.https://olympiabiosciences.com/ja/rd-hub/glp-1-companion-formulation-rd-services/https://olympiabiosciences.com/ja/rd-hub/glp-1-companion-formulation-rd-services/Drastically delayed gastric emptying and gastrointestinal distress associated with GLP-1 agonists require ultra-gentle, high-density nutrient matrices to preserve lean muscle mass.https://olympiabiosciences.com/ja/services/softgel/https://olympiabiosciences.com/ja/services/softgel/ヨーロッパ最大級のソフトジェルCDMO：3つの独立したロータリーダイカプセル化ライン、月間1億個以上のカプセル製造能力、ゼラチンおよびHPMC植物由来ソフトジェルを提供。17年間QAクレームゼロ。GMPおよびISO 22000認証済みです。https://olympiabiosciences.com/ja/services/for-doctors/https://olympiabiosciences.com/ja/services/for-doctors/オリンピアバイオサイエンス™で、医師監修のサプリメントブランドを立ち上げましょう。臨床用量でのカスタムEBM処方、HPLC/GC-MSによるバッチ検証、完全なIP移管、AI検証済み安全性スクリーニングを提供します。利益相反なし — お客様と競合することは決してありません。https://olympiabiosciences.com/ja/services/fsmp-medical-food/https://olympiabiosciences.com/ja/services/fsmp-medical-food/EU委任規則2016/128に基づく、専門的なEU規制FSMPおよび医療食品の受託製造を提供。腫瘍学FSMP、代謝栄養、術後回復処方に対応します。2009年以来、EBMに基づいた臨床栄養を製造しています。https://olympiabiosciences.com/ja/services/ip-security/https://olympiabiosciences.com/ja/services/ip-security/ISO/IEC 27001:2023に基づく情報セキュリティ監査を受けた唯一のヨーロッパCDMO。強固なNDA（秘密保持契約）フレームワーク、顧客への完全な処方IP所有権移管、消費者ブランドとの競合なし。お客様のサプリメント処方の企業秘密を保護します。https://olympiabiosciences.com/ja/services/private-label-vs-cdmo/https://olympiabiosciences.com/ja/services/private-label-vs-cdmo/決定版B2Bガイド：プライベートブランドサプリメントと真のCDMO受託製造の比較。IP（知的財産）の所有権、処方（配合）の独占性、ベンダー（供給元）の認定、そしてプレミアムサプリメントブランドがいかにして独自の処方（配合）を保護するかについて解説します。https://olympiabiosciences.com/ja/services/scaling/https://olympiabiosciences.com/ja/services/scaling/医薬品品質のPPQバリデーション（Cpk >1.33）、HPLC/GC-MSによるバッチCoA、ISO 22000 GMP、完全なサプライチェーン追跡可能性を備えた大量生産サプリメント受託製造。7桁の生産安定性を必要とするプレミアムブランドのためのスケールアップCDMOです。https://olympiabiosciences.com/ja/services/technology/https://olympiabiosciences.com/ja/services/technology/ヨーロッパで最も先進的なサプリメント処方技術：リポソームカプセル化、難溶性化合物向けナノミセル化、腸溶性DRキャップ、独自のAIカクテル効果除去技術。各バッチはHPLC/GC-MSで検証済みです。